
Is osteoarthritis treatment worth the cost? With Dr Stephanie Mathieson and Dr Giovanni Ferreira
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
In this episode of Joint Action, Professor David Hunter is joined by Dr. Stephanie Mathies and Dr. Giovanni Ferreira to unpack the cost-effectiveness of osteoarthritis treatments. They discuss the results of their recent systematic review, which analysed over 100 studies to identify which guideline-recommended treatments provide the best value for money.
From exercise and medications to injections and surgery, they explore which interventions are truly cost-effective - and which may not be worth the spend. Learn why “simple things” like exercise and education still offer the most value, and what this means for patients, clinicians, and healthcare policy.
RESOURCES
Article:
- The cost-effectiveness of guideline-recommended treatments for osteoarthritis: A systematic review: https://www.oarsijournal.com/article/S1063-4584(25)00972-0/abstract
CONNECT WITH US
- Twitter: @ProfDavidHunter @jointactionorg
- Instagram: @osteoarthritisresearchgroup
- Email: osteoarthritis.research@sydney.edu.au
- Website: https://www.jointaction.info/podcast
Hosted on Acast. See acast.com/privacy for more information.